By Kate Kelland LONDON, Sept 23 (Reuters) - West Africa's Ebola epidemic is the largest the world has ever seen, but infectious disease experts are almost as fearful of a long-term legacy in humans as they are about the deaths it is causing right now. While the current outbreak is vast and out of control, even pessimistic forecasts suggest it will eventually recede. But if the virus continues to transmit from person to person for a year or more, the risk is that Ebola will become endemic in humans and constitute an ever-present threat to people in the region and the rest of the world. ...
By Annika McGinnis WASHINGTON (Reuters) - A government nutrition program for pregnant mothers and small children has not kept pace with technology and U.S. poverty experts say its paper voucher system is driving low-income women away from the program when they need it most. The Special Supplemental Nutrition Program for Women, Infants and Children, known as WIC, has seen a sharp drop in participation since 2010, unlike food stamps and other anti-poverty programs that ballooned during the 2007-9 recession and the economic recovery that followed, government figures show. ...
By Ben Hirschler MADRID (Reuters) - It is too early to say whether combining Roche's best-selling Avastin cancer drug with the company's experimental immune-boosting medicine MPDL3280A gives a better outcome in fighting tumors. That is the verdict of experts following a presentation of a small clinical study assessing the combination in patients with a variety of solid tumors. ...
Geneva (AFP) - Swiss voters on Sunday rejected a plan for a seismic shift from the country's all-private health insurance system to a state-run scheme.
By Ben Hirschler MADRID (Reuters) - It is too early to say whether combining Roche's best-selling Avastin cancer drug with the company's experimental immune-boosting medicine MPDL3280A gives a better outcome in fighting tumors. That is the verdict of experts following a presentation of a small clinical study assessing the combination in patients with a variety of solid tumors. ...
{ 0 comments... read them below or add one }
Post a Comment